Bromide

Bromide

SCHEMBL2230104

C=CCn1cc[n+](C)c1.[Br-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
APAF1 O14727 1/20 0.47
NPC1 O15118 1/20 0.47
PLA2G1B P04054 1/20 0.47
HSP90AA1 P07900 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
LMNA P02545 1/20 0.38
FDPS P14324 2/20 0.37
PON1 P27169 1/20 0.33
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205339 0.98
Bromide SCHEMBL21777067 0.96 SMN1; SMN2 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Ammonia Solution, Strong SCHEMBL28942113 0.96 SMN1; SMN2 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Iodide SCHEMBL898865 0.96 MEN1 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Fluoride Ion SCHEMBL4200937 0.96 SMN1; SMN2 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Water SCHEMBL5809030 0.96 SMN1; SMN2 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL59757 0.96 SMN1; SMN2 (0.43) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL27711491 0.94 SMN1; SMN2 (0.42) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL23202821 0.90 SMN1; SMN2 (0.40) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL31139327 0.90 SMN1; SMN2 (0.40) SMN1; SMN2MEN1APAF1NPC1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049163-A1 SOLVENT SYSTEMS AND METHODS FOR PROCESSING CHITIN NEPTUNE NANOTECHNOLOGIES INC. (CA) 2026-02-19 US claimed
US-12476287-B2 Dual electrolyte approach for high voltage batteries URBAN ELECTRIC POWER INC. (US) 2025-11-18 US claimed
EP-4569006-A1 SOLVENT SYSTEMS AND METHODS FOR PROCESSING CHITIN Neptune Nanotechnologies Inc. (CA) 2025-06-18 EP claimed
CN-119777031-A Polysaccharide-based thermoplastic composite fiber and preparation method thereof 中国科学院化学研究所 2025-04-08 CN claimed
CN-119371560-A Method for rapidly preparing carboxymethyl cellulose from corn stalks 江南大学 2025-01-28 CN claimed
WO-2024174521-A1 PREPARATION METHOD FOR CELLULOSE-BASED MOISTURE-SENSING COLOR-CHANGING MATERIAL 齐鲁工业大学(山东省科学院) 2024-08-29 WO claimed
EP-3470493-B1 COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS PHASE CHANGE ENERGY SOLUTIONS INC (US) 2024-05-15 EP claimed
WO-2024081696-A2 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2024-04-18 WO claimed
CN-111117594-B Electrochromic material and electrochromic device based on dynamic metal-ligand complexation 吉林大学 2024-03-26 CN claimed
WO-2024031186-A1 SOLVENT SYSTEMS AND METHODS FOR PROCESSING CHITIN NEPTUNE NANOTECHNOLOGIES INC. (CA) 2024-02-15 WO claimed
US-9449797-B2 Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface LAM RESEARCH CORPORATION (US) 2016-09-20 US claimed
CN-105734605-A Electrochemical oxidation synthesis method of dimethoxymethane 哈尔滨师范大学 2016-07-06 CN claimed
US-20150372351-A1 PROCESSES FOR PREPARING L-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS BROMINE COMPOUNDS LTD. (IL) 2015-12-24 US claimed
US-20150345034-A1 SYSTEMS, METHODS, AND MATERIALS FOR PRODUCING HYDROCARBONS FROM CARBON DIOXIDE INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) 2015-12-03 US claimed
CN-105026371-A Process for preparing 1-alkyl-3-alkyl-pyridinium bromides and their use as additives in electrochemical cells BROMINE COMPOUNDS LTD 2015-11-04 CN claimed
US-20150155584-A1 ADDITIVES FOR ZINC-BROMINE MEMBRANELESS FLOW CELLS BROMINE COMPOUNDS LTD. (IL) 2015-06-04 US claimed
US-20140335698-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION (US) 2014-11-13 US claimed
US-8877988-B2 Synthesis of 1-BROM0-3,3,3-trifluoropropene HONEYWELL INTERNATIONAL INC. (US) 2014-11-04 US claimed
US-20140179960-A1 SYNTHESIS OF 1-BROMO-3,3,3-TRIFLUOROPROPENE HONEYWELL INTERNATIONAL INC. (US) 2014-06-26 US claimed
US-20130165353-A1 STABLE SUSPENSIONS OF CARBON NANOPARTICLES FOR NANO-ENHANCED PDC, LBL COATINGS, AND COOLANTS BAKER HUGHES INCORPORATED (US) 2013-06-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372351-A1 PROCESSES FOR PREPARING L-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS PLP2, PLPBP, AZI2 SMN1; SMN2 2981/4885MEN1 2806/4885APAF1 1513/4885
US-20260049163-A1 SOLVENT SYSTEMS AND METHODS FOR PROCESSING CHITIN CHI3L1, CHI3L2, CHIA SMN1; SMN2 1706/4885MEN1 375/4885APAF1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.